Willing to return to enrolling medical site for all study assessments
Willingness to return to enrolling institution for follow-up
Willing to return to enrolling institution for follow-up
Willing to return to enrolling institution for follow-up for a minimum of 1 year
Willing to return to enrolling institution for follow-up during the active treatment; event monitoring following completion of therapy may occur outside the enrolling institution
Willing to return to enrolling institution for follow-up
Willing to return to enrolling institution for follow-up
Willingness to return to the enrolling medical site for all study assessments
Willing to return to enrolling institution for follow-up
Willingness to return to enrolling institution for follow-up
Willing to return to enrolling institution for follow-up (during the treatment and observation phases of the study)
Willing to return to enrolling institution for follow-up
Willingness to return to enrolling institution for follow up
Willing to return to enrolling institution for follow-up 2-4 weeks after treatment discontinuation
Willing to return to participating medical institutions for follow-up
Willing to return to enrolling institution for follow-up
Willing to return to Academic and Community Cancer Research United (ACCRU) enrolling institution for follow-up
Willingness to return to a lymphoma Specialized Program of Research Excellence (SPORE) enrolling institution for follow-up
Willing to return to consenting institution for follow-up during the study
Willing to return to enrolling institution for follow-up
Willing to return to Alliance enrolling institution for follow-up
Willingness to return to the Alliance enrolling institution for follow-up
After the week-long study treatment, participants must be willing to return to the enrolling institution for a follow-up visit
Willing to return to enrolling institution for follow-up of the study and optional crossover (if applicable)
Willing to return to an Alliance enrolling institution for follow-up
Willingness to return to the enrolling institution for follow-up
Willing to undergo monthly follow-up assessment, either in person at the enrolling institution or by telephone
Willingness to return to the enrolling site for the study surgical procedures, including pre-operative and post-operative care; (patients in the ISDO arm must be willing to return to the enrolling site for yearly ovarian cancer assessment)
Willingness to return to the enrolling site for any surgical procedures including pre-operative and post-operative care
Willingness to return to the enrolling site for ovarian cancer screening during the study period
